代谢疾病SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways.
期刊：Cell death & disease发表年份：2016作者：T T Zhou; L L Quan; L P Chen; T Du; K X Sun; J C Zhang; L Yu; Y Li; P Wan; L L Chen; B H Jiang; L H Hu; J Chen; X Shen
代谢疾病Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.
期刊：Journal of medicinal chemistry发表年份：2016作者：Herbert H Seltzman; Craig Shiner; Erin E Hirt; Anne F Gilliam; Brian F Thomas; Rangan Maitra; Rod Snyder; Sherry L Black; Purvi R Patel; Yatendra Mulpuri; Igor Spigelman
